MedTrace Logo

Effect of Glucose Control on the Response to Aspirin in Type 2 Diabetic Patients

NCT00649909 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 18

Last updated 2017-08-10

No results posted yet for this study

Summary

The efficacy of low dose aspirin appears to be substantially lower in diabetic patients, compared to patients without diabetes.

We will perform an observational study where we follow up patients with uncontrolled type 2 Diabetes Mellitus and low response to aspirin (Aspirin Resistance), during a period of 6 months in the diabetic clinic. Our hypothesis is that glucose control will improve the response to aspirin in those patients.

Conditions

  • Diabetes Mellitus, Type II

Sponsors & Collaborators

  • Hadassah Medical Organization

    lead OTHER

Principal Investigators

  • David Varon, MD · Hematology Department, Hadassah Medical Organization, Jerusalem, Israel

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-11-30
Primary Completion
2010-11-30
Completion
2010-11-30

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00649909 on ClinicalTrials.gov